Mersana Therapeutics, Inc. (MRSN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1157510,
    "name": "Mersana Therapeutics, Inc.",
    "stock_name": "Mersana Therapeutics, Inc.",
    "full_name": "Mersana Therapeutics, Inc.",
    "name_url": "stocks-analysis/mersana-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "27.47",
    "chg": -0.05,
    "chgp": "-0.18%",
    "dir": -1,
    "prev_price": "27.52",
    "mcapval": "35.13",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US59045L1061",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "64.62 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mersana-therapeutics-inc-1157510-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Mersana Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-mersana-therapeutics-inc-technically-bullish-or-bearish-3547236",
        "imagepath": "",
        "date": "2025-09-20 19:50:24",
        "description": "As of 8 September 2025, the technical trend for Mersana Therapeutics, Inc. has changed from bullish to mildly bullish. The MACD indicates a mildly bullish stance on both weekly and monthly time frames, while the RSI shows a bullish signal on the monthly but no signal on the weekly. However, the Bollinger Bands and moving averages present a bearish outlook on the daily, with the daily moving averages specifically indicating bearish momentum. The KST is mildly bullish on the weekly but bearish on the monthly, and the OBV is mildly bullish on the weekly with no trend on the monthly.\n\nIn terms of performance, the stock has significantly underperformed compared to the S&P 500 across all time frames, with a year-to-date return of -79.44% versus the S&P 500's 12.22%, and a one-year return of -86.13% compared to the S&P 500's 17.14%. Overall, the current technical stance is mildly bullish, but the significant under..."
      },
      {
        "title": "Is Mersana Therapeutics, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-mersana-therapeutics-inc-overvalued-or-undervalued-3543647",
        "imagepath": "",
        "date": "2025-09-20 18:24:53",
        "description": "As of 9 May 2022, Mersana Therapeutics, Inc. has moved from a grade of does not qualify to risky. The company is currently overvalued based on its financial metrics. Key valuation ratios include a Price to Book Value of -1.56, an EV to EBIT of 0.39, and an EV to EBITDA of 0.40, which indicate significant concerns regarding its valuation relative to its peers.\n\nIn comparison to its industry peers, Mersana's EV to EBITDA ratio of 0.40 is more favorable than Harpoon Therapeutics, Inc. at -13.4119 and Selecta Biosciences, Inc. at -2.6957, but still reflects a risky valuation environment. The company's stock has underperformed significantly, with a year-to-date return of -79.44% compared to the S&P 500's positive return of 12.22%, reinforcing the notion that Mersana is overvalued in the current market context...."
      }
    ],
    "total": 7,
    "sid": "1157510",
    "stock_news_url": "https://www.marketsmojo.com/news/mersana-therapeutics-inc-1157510"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Mersana Therapeutics, Inc. technically bullish or bearish?

2025-09-20 19:50:24

As of 8 September 2025, the technical trend for Mersana Therapeutics, Inc. has changed from bullish to mildly bullish. The MACD indicates a mildly bullish stance on both weekly and monthly time frames, while the RSI shows a bullish signal on the monthly but no signal on the weekly. However, the Bollinger Bands and moving averages present a bearish outlook on the daily, with the daily moving averages specifically indicating bearish momentum. The KST is mildly bullish on the weekly but bearish on the monthly, and the OBV is mildly bullish on the weekly with no trend on the monthly. In terms of performance, the stock has significantly underperformed compared to the S&P 500 across all time frames, with a year-to-date return of -79.44% versus the S&P 500's 12.22%, and a one-year return of -86.13% compared to the S&P 500's 17.14%. Overall, the current technical stance is mildly bullish, but the significant under...

Is Mersana Therapeutics, Inc. overvalued or undervalued?

2025-09-20 18:24:53

As of 9 May 2022, Mersana Therapeutics, Inc. has moved from a grade of does not qualify to risky. The company is currently overvalued based on its financial metrics. Key valuation ratios include a Price to Book Value of -1.56, an EV to EBIT of 0.39, and an EV to EBITDA of 0.40, which indicate significant concerns regarding its valuation relative to its peers. In comparison to its industry peers, Mersana's EV to EBITDA ratio of 0.40 is more favorable than Harpoon Therapeutics, Inc. at -13.4119 and Selecta Biosciences, Inc. at -2.6957, but still reflects a risky valuation environment. The company's stock has underperformed significantly, with a year-to-date return of -79.44% compared to the S&P 500's positive return of 12.22%, reinforcing the notion that Mersana is overvalued in the current market context....

View All News